SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-035407
Filing Date
2024-04-23
Accepted
2024-04-23 16:44:35
Documents
15
Period of Report
2024-04-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204491-8k425_10xcap3.htm   iXBRL 8-K 34016
2 PRESS RELEASE, DATED APRIL 23, 2024 ea020449101ex99-1_10xcap3.htm EX-99.1 5901
  Complete submission text file 0001213900-24-035407.txt   272875

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vcxb-20240417.xsd EX-101.SCH 4221
4 XBRL DEFINITION FILE vcxb-20240417_def.xml EX-101.DEF 27375
5 XBRL LABEL FILE vcxb-20240417_lab.xml EX-101.LAB 38052
6 XBRL PRESENTATION FILE vcxb-20240417_pre.xml EX-101.PRE 25995
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0204491-8k425_10xcap3_htm.xml XML 7659
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 24865410
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)